These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 35079988)
21. Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms. Garcia-Romeu A; Darcy S; Jackson H; White T; Rosenberg P Curr Top Behav Neurosci; 2022; 56():287-317. PubMed ID: 34734390 [TBL] [Abstract][Full Text] [Related]
23. A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961-76. Johnstad PG Hist Psychiatry; 2020 Jun; 31(2):217-226. PubMed ID: 31928087 [TBL] [Abstract][Full Text] [Related]
24. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics. Tófoli LF; de Araujo DB Int Rev Neurobiol; 2016; 129():157-85. PubMed ID: 27503452 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. van Elk M; Yaden DB Neurosci Biobehav Rev; 2022 Sep; 140():104793. PubMed ID: 35878791 [TBL] [Abstract][Full Text] [Related]
35. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Carhart-Harris RL; Goodwin GM Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617 [TBL] [Abstract][Full Text] [Related]
36. The renaissance in psychedelic research: What do preclinical models have to offer. Murnane KS Prog Brain Res; 2018; 242():25-67. PubMed ID: 30471682 [TBL] [Abstract][Full Text] [Related]
37. Psychedelics and music: neuroscience and therapeutic implications. Barrett FS; Preller KH; Kaelen M Int Rev Psychiatry; 2018 Aug; 30(4):350-362. PubMed ID: 30240282 [TBL] [Abstract][Full Text] [Related]
38. Neuropharmacological modulation of the aberrant bodily self through psychedelics. Ho JT; Preller KH; Lenggenhager B Neurosci Biobehav Rev; 2020 Jan; 108():526-541. PubMed ID: 31816361 [TBL] [Abstract][Full Text] [Related]